Skip to content

Homoeopathic treatment for emotional dysregulation of women with chronic pelvic pain from gynaecological disorders.

Role of individualized homoeopathic medicine in emotional dysregulation of women with chronic pelvic pain from gynaecological disorders- a single arm pre-post clinical study. - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/05/066936
Enrollment
40
Registered
2024-05-07
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R102- Pelvic and perineal pain

Interventions

Intervention1: Individualized Homoeopathic medicine in suitable potency.: All patients will be prescribed individualized homoeopathic medicine after detailed case taking in accordance with the direct

Sponsors

National Institute of Homoeopathy.
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patients with chronic pelvic pain having clinical symptoms of gynaecological disorders, with or without findings in ultrasonography abdomen and pelvis. 2. Female patients of 18- 50 years of age 3. Patients with chronic pelvic pain showing any findings of gynaecological disorders in ultrasonography abdomen and pelvis. 4. Patients who score 19 or below in cognitive reappraisal and 7 or above for expressive suppression in Emotion Regulation Questionnaire (ERQ) 32 5. Patients who can read/ understand either English, Hindi, Bengali. 6. Patients who are willing to participate in study and giving written informed consent.

Exclusion criteria

Exclusion criteria: 1.Patient suffering from pelvic pain only during menstrual cycle. 2. Patients who have attained menopause 3. Patients suffering from chronic pelvic pain due to urological, gastrointestinal, musculoskeletal or neurological disorders. 4. Patients who are pregnant, lactating, taking OCP or done hysterectomy. 5. Patients who are taking medications for any other chronic disease. 6. Patients who are diagnosed with life threatening diseases, systemic illness, immunocompromised states, psychiatric illness and malignancy. 7. Substance abuse and/or dependence.

Design outcomes

Primary

MeasureTime frame
Difficulty in Emotion Regulation Scale. (DERS)Timepoint: Baseline and 6th month.

Secondary

MeasureTime frame
Functional Pelvic Pain Scale (FPPS)Timepoint: Baseline and 6th month

Countries

India

Contacts

Public ContactProf Dr Ompriya Mishra

National Institute of Homoeopathy.

drompriyanih@gmail.com8240359414

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026